Clinical Trials - Tuberculosis
-
A5384: A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents with Tuberculous Meningitis
Study Location: India
Eligibility: Target Participant Age 15 years and older Definite, probable, or possible TBM diagnosis from testing performed as part of...
Enrollment: Open
-
Identification of Biomarkers That Can Predict Progression from Latent Tuberculosis Infection to Active Tuberculosis Disease
Study Location: India
Eligibility: Adult, Pediatric, Household contacts
Enrollment: Open
-
A5300B/I2003B/PHOENIX, Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
Study Location: India
Eligibility: Men and women age greater than or equal to 18 year
Enrollment: Open